Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Cash from Financing Activities (2016 - 2020)

Historic Cash from Financing Activities for Larimar Therapeutics (LRMR) over the last 8 years, with Q4 2020 value amounting to $242000.0.

  • Larimar Therapeutics' Cash from Financing Activities fell 9299.57% to $242000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $93.6 million, marking a year-over-year increase of 38253.16%. This contributed to the annual value of $161.9 million for FY2024, which is 53951000.0% up from last year.
  • Latest data reveals that Larimar Therapeutics reported Cash from Financing Activities of $242000.0 as of Q4 2020, which was down 9299.57% from -$135000.0 recorded in Q3 2020.
  • In the past 5 years, Larimar Therapeutics' Cash from Financing Activities ranged from a high of $83.9 million in Q2 2020 and a low of -$756000.0 during Q4 2016
  • Moreover, its 5-year median value for Cash from Financing Activities was $168500.0 (2019), whereas its average is $9.7 million.
  • Per our database at Business Quant, Larimar Therapeutics' Cash from Financing Activities plummeted by 30055.25% in 2016 and then soared by 3285000.0% in 2019.
  • Larimar Therapeutics' Cash from Financing Activities (Quarter) stood at -$756000.0 in 2016, then skyrocketed by 2577.51% to $18.7 million in 2017, then tumbled by 90.62% to $1.8 million in 2018, then surged by 96.64% to $3.5 million in 2019, then plummeted by 93.0% to $242000.0 in 2020.
  • Its Cash from Financing Activities was $242000.0 in Q4 2020, compared to -$135000.0 in Q3 2020 and $83.9 million in Q2 2020.